Subscribe to Pro or Enterprise plans to unlock this feature.
Become a smarter investor today.
Become a smarter investor today.
This statistic highlights Pfizer’s Revenue Breakdown by Wholesaler from 2013 onwards split across AmerisourceBergen, Cardinal Health, McKesson, and Others/Unclassified.
Pfizer Inc. is a global biopharmaceutical company. Its revenue comes from the manufacture and sale of their products, mainly biopharmaceutical products, and, from alliance agreements, under which they co-promote products discovered or developed by them or other companies. They seek to promote wellness, prevention, treatments, and cures for the world’s most serious illnesses in developed and emerging economies.
Pfizer distributes its products through the following wholesalers:
|Wholesaler||Revenue in 2019||Revenue in 2020||Revenue share in 2020||YoY Growth|
(All figures in billions, except percentages)
In 2020, the United States accounted for 52% of Pfizer’s revenue, while China and Japan each contributed 6% and other nations accounted for 36%.
Pfizer’s revenue is bifurcated among the following wholesalers:
AmerisourceBergen is a company based in the United States handling nearly 20% of all medications supplied in the United States. They offer drug distribution as well as medical business operations and patient care consultancy. AmerisourceBergen has 26 pharmaceutical distribution facilities in the United States and nine in Canada. They also have four specialized distribution facilities in the United States and more than one million square feet of packaging & manufacturing capacity in the United States and the United Kingdom.
Pfizer’s revenue from AmerisourceBergen stood at $5.45 billion in 2020. It witnessed a growth of 20% when compared to $4.53 billion earned in 2019. AmerisourceBergen accounted for 13% of Pfizer’s revenue in 2020.
Cardinal Health, Inc. is a worldwide healthcare services firm based in the United States that specializes in the distribution of medications and medical devices to over 100,000 locations. It has the country’s largest network of radiopharmacies. Over 75 per cent of hospitals in the United States use Cardinal Health’s medical products.
In 2020, Cardinal Health accounted for 10% of Pfizer’s revenue amounting to $4.19 billion. It was a 13% increase compared to $3.71 billion earned in the year 2019.
McKesson Corporation is a pharmaceutical distributor and provides health information technology, medical supplies, and care management solutions, and large network infrastructure for the health care industry in the United States. A third of the drugs used in North America are delivered by this corporation.
Pfizer’s revenue from McKesson rose from $6.18 billion in 2019 to $6.71 billion in 2020, marking an increase of 9% on a year-on-year basis. McKesson contributed to 16% of Pfizer’s total revenue in 2020.
Others/Unclassified consist of wholesalers who are not listed above. Pfizer’s other wholesalers include Amatheon Inc, AMD Pennsylvania LLC, Mountainside Medical Equipment Inc, Orion Medical Supply Inc, Caligor Pharmacy & Medical Supplies, Fisher Bioservices Rockville, National Cornerstone Healthcare Service Inc, Hanna’s Pharmaceutical Supply Co Inc, Medical Specialties Distributors LLC, and more.
Pfizer’s Others/Unclassified wholesalers generated $25.56 billion in revenue in 2020, down by 4% from $26.76 billion generated in 2019. Others/Unclassified wholesalers accounted for the majority of Pfizer’s sales in 2020, accounting for 61% of total revenue.
Pfizer Inc. is an American-based pharmaceutical and biotechnology company. Their headquarters is situated in Manhattan, New York City. The company is named after its co-founder Charles Pfizer. Pfizer’s common stocks are traded on NYSE under the trading symbol ‘PFE’. On the Fortune 500, the company is ranked 64th, while on the Forbes Global 2000, it is ranked 49th. As of 2020, the number of employees of the company worldwide was 78,000.
Pfizer Inc. uses science and its global resources to bring therapies to people around the world that extend and improve their lives through the invention, advancement, production, marketing, sales, and distribution of biopharmaceutical products. They work with healthcare professionals, governments, and local communities all around the globe to promote and extend access to safe, affordable healthcare.
Over the years, Pfizer has acquired many companies such as Warner-Lambert, Pharmacia, Wyeth, King pharmaceuticals, Anacor pharmaceuticals, Arixa Pharmaceuticals, and Amplyx Pharmaceuticals. Pfizer and BioNTech signed an agreement for the production of the COVID-19 vaccine in March 2020. GlaxoSmithKline, AbbVie, Merck & Co., Eli Lilly & Co., Bristol Myers Squibb, Novartis AG, and Johnson & Johnson are among Pfizer’s top competitors.
Did you like Pfizer’s Revenue Breakdown by Wholesaler statistic?
Access thousands of more such key performance indicator data points, on listed companies, with Business Quant.
You can also get started for free.
Always know what you’ll pay. No hidden costs or surprises.
* Billed annually, local taxes extra.
* Local taxes extra.